POSTERS ASCO 2024

Cáncer gastrointestinal

Gastroesofágico, pancreático y hepatobiliar

Interim results of the randomized phase 2 cohort of study FW-2020-01 assessing the efficacy, safety and pharmacodynamics of CM24 in combination with nivolumab and chemotherapy in advanced/metastatic pancreatic cancer.

Interim results of the randomized phase 2 cohort of study FW-2020-01 assessing the efficacy, safety and pharmacodynamics of CM24 in combination with nivolumab and chemotherapy in advanced/metastatic pancreatic cancer.

Abstract: LBA4143 Poster Bd #: 123

Poster

Descargar

Autor
Teresa Macarulla, MD, PhD

Gastrointestinal and Endocrine Tumor Unit Vall d'Hebron University Hospital and Vall d'Hebrón Institute of Oncology (VHIO)

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON